
Overall, Novozymes made progress in 2016. The enzyme producer's revenue increased slightly by 1 percent to DKK 14,142 million (EUR 1,902 million) while the result landed a good 7 percent above 2015 at DKK 3,881 before taxes, according to the annual report presented Wednesday morning.
However, the progress is not a result of positive trends in the biofuel business. As the only one of Novozyme's five divisions, it suffered an unsurprising setback with revenue of DKK 2,438 million, which is 4 percent less than the previous year.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app